The MR Fusion arrives at Nova Scotia Health (Video - 2:15)
Nova Scotia Health’s QEII Health Sciences Centre made history again in the fall of 2022, becoming the first hospital in Atlantic Canada to use advanced real-time technology that fuses magnetic resonance images with ultrasound images, to allow more precise guided biopsies of suspected prostate cancer.
Thanks to a collaboration by the departments of urology and diagnostic imaging, Nova Scotia Health’s Information Management and Technology team (IM/IT) and the @QEII Foundation, the QEII Health Sciences Centre has purchased new technology that fuses MR images of the prostate with ultrasound-guided biopsy images, allowing much clearer, live visualization of the biopsy needle path. The system, one of only a few adopted into clinical practice in Canada, will be used for select patients meeting the criteria, who are referred by their urologist.
Prostate cancer is among the most common and treatable forms of cancer and this technology is allowing Nova Scotia to remain current with the latest standards and technology to support timely diagnosis and treatment.
Generous QEII Foundation donors funded approximately $450,000 of the $600,000 cost of the new equipment and software.